contract development and manufacturing organization
Sirio Furthers Global Expansion With Thai Multipurpose Manufacturing Investment
SIRIO Pharma (China), the global nutraceutical contract development and manufacturing organization (CDMO), has announced plans to commence work on a new production site in Chonburi, Thailand. On the back of record revenues during 2023 – Sirio announced in May, 2024 a 42.87 percent year-on-year revenue rise to $508 million [€469 million] – the CDMO is continuing ...
SIRIO Launches Its First ‘Smart Factory’
SIRIO, a nutraceutical contract development and manufacturing organization (CDMO), has completed a new “smart factory” at its Ma’anshan, China site, with Internet of Things (IoT) enabled automated processes and monitoring, intelligent distribution robotics and artificial intelligence (AI). SIRIO is a first adopter of smart factory tech (industry 4.0) among nutraceutical manufacturers, bringing a level of ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listings:
